AC
TEVA icon

Alexandria Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Alexandria Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2
Closed – – 643
2016
Q4 		$0 Sell
2
-1
-33% -$40 ﹤0.01% 617
2016
Q3 		$0 Sell
3
-50
-94% -$2.61K ﹤0.01% 637
2016
Q2 		$3K Hold
53
– – ﹤0.01% 531
2016
Q1 		$3K Buy
+53
New +$3.11K ﹤0.01% 536
2015
Q2 		– Sell
-85
Closed -$5K – 644
2015
Q1 		$5K Buy
+85
New +$4.94K ﹤0.01% 488
2014
Q2 		– Sell
-100
Closed -$5K – 618
2014
Q1 		$5K Hold
100
– – ﹤0.01% 457
2013
Q4 		$4K Hold
100
– – ﹤0.01% 495
2013
Q3 		$4K Hold
100
– – ﹤0.01% 496
2013
Q2 		$4K Buy
+100
New +$3.89K ﹤0.01% 538

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Alexandria Capital's TEVA Position: Q1 2017 in Review

Alexandria Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2017, closing a stake of 2 shares.

Alexandria Capital first reported a position in TEVA in Q2 2013 and held it in 9 quarters. The position peaked at $5K in Q1 2015. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Alexandria Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2017 after selling out during the quarter.
  • Alexandria Capital sold 2 Teva Pharmaceutical Industries Limited shares in Q1 2017.
  • Alexandria Capital first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 9 quarters.
  • Alexandria Capital's Teva Pharmaceutical Industries Limited position peaked at $5K in Q1 2015.
  • 688 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2017.

Based on Alexandria Capital's 13F filing for Q1 2017, filed 25 Apr 2017.